The Division of Child and Adolescent Psychiatry at Cincinnati Children’s has a strong interest in promoting clinical research experiences for residents. Residents may participate in a variety of research protocols with faculty members.

Research Studies

  • Long-Chain Omega-3 Fatty Acid Biostatus and Hippocampal Function in Adolescent Depressive Disorders
  • Developing a Standardized Risk Assessment Approach to Improve School Safety
  • Functional connectivity in infants with Fragile X Syndrome and high risk infant siblings of individuals with Autism Spectrum Disorder
  • Pilot Proof of Concept Study of AZD7325 in Adults with Fragile X Syndrome
  • Mechanisms of Neocortical and sensory Hyperexcitability in Fragile X Syndrome
  • Pilot Signal Funding Study of AZD7325 in Adults with Fragile X Syndrome
  • SFARI Autism Cohort
  • Acamprosate in Fragile X Syndrome
  • Using Longitudinal Data to Characterize the Natural History of Fragile X Syndrome to Improve Services and Outcomes-Component C
  • An initial Double-Blind Placebo-Controlled Two-Dose Crossover Study of AZD7325 in Adults with Fragile X Syndrome
  • Identifying and Embedding Brokers into a Multi-tiered System of Services to Reduce the Bystander Effect Leading to a Reduction in School Violence
  • Research on Children in Military Families: The impact of Parental Family Deployment and Reintegration on Child and Family Functioning
  • Frontal Cortical Gamma Oscillations Mark Contamination Obsessions in Youth
  • Anomalous Sensorimotor Physiology in Fragile X Syndrome
  • Mobility: Improving Patient-Centered Outcomes Among Overweight and Obese Youth with Bipolar Spectrum Disorders Treated with Second-Generation Antipsychotics
  • Phenotyping of the Severely Affected Autism Population
  • Sertraline Pediatric Registry for The Evaluation of Safety
  • Clinical trial involving an investigational device called the Social Developmental Testing Device
  • Ketamine Use in Autism Spectrum Disorder: A Placebo Controlled Pilot Study
  • Autism Spectrum Disorder Metabolite Stability Study
  • Children's Autism Metabolome Project: Development and Clinical Evaluation  of the Stemina Metabolic Biomarker-Based Test to Diagnose Autism Spectrum Disorder in Early Childhood
  • A Phase 2 Adult Angelman Syndrome Clinical Trial: A Randomized, Double-blind safety and Efficacy study of Gaboxadol, STARS
  • A Phase 2 Multi-Center, Randomized, Double-Blind, 24 Week, 3-Arm, Parallel Group, Placebo-Controlled Study to Investigate the Efficacy and Safety of RO5285119 in Children and Adolescents Age 5-17 with Autism Spectrum Disorder